Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Research Biochemicals (CRB) is a leading independent producer of custom-made peptides and antibodies for the pharmaceutical, life science, and academic communities. Founded in 1980, the company specializes in complex peptide synthesis, including radiolabeling and fluorescent tagging, as well as the development of high-quality custom antibodies. CRB provides essential tools for drug discovery and development, supporting researchers in identifying and validating biological targets. The company operates from its headquarters in Billingham, UK, and serves a global client base, maintaining a reputation for technical expertise in handling difficult-to-synthesize sequences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambridge Research.